phorbol 12,13-dibutyrate has been researched along with hns 32 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, K; Igarashi, T; Imai, T; Mitani, A; Nakazawa, T; Noguchi, K; Otsuka, K; Saitoh, M; Shigenobu, K; Someya, S; Tanaka, H; Tanaka, Y; Yamaki, F | 1 |
Nakazawa, T; Noguchi, K; Saitoh, M; Shigenobu, K; Tanaka, H; Tanaka, Y | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and hns 32
Article | Year |
---|---|
HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Calcium Channel Blockers; Colforsin; Endothelium, Vascular; Enzyme Activation; In Vitro Techniques; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitroglycerin; Norepinephrine; Phorbol 12,13-Dibutyrate; Potassium Channel Blockers; Potassium Chloride; Protein Kinase C; Pyridines; Rabbits; Tetraethylammonium; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Cerebral artery selective inhibition of protein kinase c-mediated contraction by hns-32, a novel azulene-1-carboxamidine derivative.
Topics: Animals; Anti-Arrhythmia Agents; Basilar Artery; Cerebral Arteries; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyridines; Vasoconstrictor Agents; Vasodilator Agents | 2000 |